SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma
- 1 April 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 43 (4) , 232-238
Abstract
Background: Planar whole-body imaging with 123I-radiolabeled metaiodobenzylguanidine (123I-MIBG) is routinely used in the follow-up evaluation of neuroblastoma. In recent years, SPECT with integrated low-dose CT (SPECT/CT) has become more accessible. We investigated how much SPECT/CT can have additional diagnostic value over planar imaging in detection of residual and recurrent neuroblastoma. Methods: A total of 170 planar 123I-MIBG imaging scans with SPECT/CT follow-up scans performed in 147 patients with known high-risk neuroblastoma were retrospectively analyzed. Regions of increased 123I-MIBG uptake on planar images and the findings on SPECT/CT were compared. Results: In 61% of the studies, the whole-body planar images and SPECT/CT images yielded the same result. In 39% of the time, however, SPECT/CT images provided additional information. Conclusions: In the follow-up of patients with high-risk neuroblastoma, SPECT/CT can significantly improve planar imaging interpretation and impact patient management.Keywords
This publication has 34 references indexed in Scilit:
- Pediatric Radiopharmaceutical Administered Doses: 2010 North American Consensus GuidelinesJournal of Nuclear Medicine, 2011
- Comparison of Diagnostic Value of I-123 MIBG and High-Dose I-131 MIBG Scintigraphy Including Incremental Value of SPECT/CT Over Planar Image in Patients With Malignant Pheochromocytoma/Paraganglioma and NeuroblastomaClinical Nuclear Medicine, 2011
- False-Positive MIBG Uptake in Pneumonia in a Patient With Stage IV NeuroblastomaClinical Nuclear Medicine, 2010
- False-positive radio-iodinated metaiodobenzylguanidine (123I-MIBG) accumulation in a mast cell-infiltrated infantile haemangiomaBritish Journal of Radiology, 2010
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk NeuroblastomaJournal of Clinical Oncology, 2009
- SPECT/CTJournal of Nuclear Medicine, 2008
- Scintigraphic Response by 123I-Metaiodobenzylguanidine Scan Correlates With Event-Free Survival in High-Risk NeuroblastomaJournal of Clinical Oncology, 2004
- Biodistribution of post‐therapeutic versus diagnostic 131I‐MIBG scans in children with neuroblastomaPediatric Blood & Cancer, 2003
- False positive MIBG scan due to accessory spleenMedical and Pediatric Oncology, 2001